{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:33:49Z","timestamp":1780749229709,"version":"3.54.1"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["GM126412"],"award-info":[{"award-number":["GM126412"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Genetic, hormonal, anatomical, and environmental factors underlie sex differences in the prevalence and progression of cardiovascular disease and responses to therapeutics. The presence of two X chromosomes in the female genome decreases susceptibility to X-linked recessive disorders but imposes the need for random X chromosome inactivation as an epigenetic mechanism controlling gene dosage. Long non-coding RNA XIST is essential for transcriptional repression of genes on inactive X chromosome but may also act as a miRNA sponge for post-transcriptional regulation of gene expression and a scaffold for RNA binding proteins that provoke autoimmune responses. These features draw attention to XIST as an important drug development target by design or as an off target, including novel RNA therapeutics for genetic and cardiovascular diseases. Based on the extensive literature analysis, we postulate the hypothesis that XIST can determine sex differences in cardiovascular drug responses and propose several criteria for use in developing or evaluating responses to RNA therapeutics for cardiovascular disease in women. We hope that implementation of those criteria in the process of RNA therapeutics development may be helpful in reducing the risks of adverse effects in women.<\/jats:p>","DOI":"10.3389\/fphar.2025.1716863","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:38:48Z","timestamp":1768196328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["X-inactive specific transcript (XIST) can determine sex differences in cardiovascular drug responses: focus on RNA therapeutics"],"prefix":"10.3389","volume":"16","author":[{"given":"Timur O.","family":"Yarovinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod S.","family":"Ramgolam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva R.","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina S.","family":"Stachenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.121.054108","article-title":"Genes that escape X chromosome inactivation modulate sex differences in valve myofibroblasts","volume":"145","author":"Aguado","year":"2022","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/S41586-022-04537-Z","article-title":"Targeting Xist with compounds that disrupt RNA structure and X inactivation","volume":"604","author":"Aguilar","year":"2022","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41431-022-01115-9","article-title":"Silencing XIST on the future active X: searching human and bovine preimplantation embryos for the repressor","volume":"32","author":"Aksit","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1038\/S44319-025-00499-1","article-title":"X chromosome inactivation in mammals: general principles and species-specific considerations","volume":"26","author":"Alfeghaly","year":"2025","journal-title":"EMBO Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/S41594-024-01325-3","article-title":"XIST dampens X chromosome activity in a SPEN-dependent manner during early human development","volume":"31","author":"Alfeghaly","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B6","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/2326-6066.CIR-23-0127","article-title":"Immune modulation of innate and adaptive responses restores immune surveillance and establishes antitumor immunologic memory","volume":"12","author":"Alvero","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nbt1018-911b","article-title":"Akcea\u2019s antisense drug rejection worries analysts","volume":"36","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.tig.2016.03.007","article-title":"Escape artists of the X chromosome","volume":"32","author":"Balaton","year":"2016","journal-title":"Trends Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Mol. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/S10557-022-07391-3","article-title":"RNA editing therapeutics: advances, challenges and perspectives on combating heart disease","volume":"37","author":"Birgaoanu","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ceb.2020.11.004","article-title":"Xist-mediated chromatin changes that establish silencing of an entire X chromosome in mammals","volume":"70","author":"Boeren","year":"2021","journal-title":"Curr. Opin. Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1172\/JCI33166","article-title":"No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans","volume":"118","author":"Bolduc","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ymthe.2023.01.005","article-title":"RNA editing: expanding the potential of RNA therapeutics","volume":"31","author":"Booth","year":"2023","journal-title":"Mol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0092-8674(92)90520-M","article-title":"The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus","volume":"71","author":"Brown","year":"1992","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/cells11203328","article-title":"mRNA-based approaches to treating liver diseases","volume":"11","author":"Cacicedo","year":"2022","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1003853","DOI":"10.1371\/journal.pgen.1003853","article-title":"Genetic architecture of skewed X inactivation in the laboratory mouse","volume":"9","author":"Calaway","year":"2013","journal-title":"PLoS Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E668","DOI":"10.1073\/pnas.1715124115","article-title":"A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders","volume":"115","author":"Carrette","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","article-title":"The biogenesis and emerging roles of circular RNAs","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e3011","DOI":"10.1038\/cddis.2017.421","article-title":"Long noncoding rna xist expedites metastasis and modulates epithelial\u2013mesenchymal transition in colorectal cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bbrc.2018.09.135","article-title":"The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p","volume":"505","author":"Chen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/J.OMTN.2020.03.015","article-title":"Treatment of hemophilia A using factor VIII messenger RNA lipid nanoparticles","volume":"20","author":"Chen","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/J.APSB.2023.08.034","article-title":"Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/S41388-024-02994-6","article-title":"Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR-211-5p\/GDNF","volume":"43","author":"Cheng","year":"2024","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2015.03.025","article-title":"Systematic discovery of Xist RNA binding proteins","volume":"161","author":"Chu","year":"2015","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/S00412-007-0100-1","article-title":"XIST RNA exhibits nuclear retention and exhibits reduced association with the export factor TAP\/NXF1","volume":"116","author":"Cohen","year":"2007","journal-title":"Chromosoma"},{"key":"B31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2012.01.015","article-title":"Barth syndrome in a female patient","volume":"106","author":"Cosson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular mechanisms of antisense oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/S41573-021-00162-Z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"","journal-title":"Nat. Rev. Drug Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.jbc.2021.100416","article-title":"Antisense technology: a review","volume":"296","author":"Crooke","year":"","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/11887","article-title":"Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation","volume":"22","author":"Csankovszki","year":"1999","journal-title":"Nat. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.116.026668","article-title":"Sex bias is increasingly prevalent in preclinical cardiovascular research: implications for translational medicine and health equity for women: a systematic assessment of leading cardiovascular journals over a 10-Year period","volume":"135","author":"Daniel Ramirez","year":"2017","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ymthe.2020.02.001","article-title":"Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells","volume":"28","author":"De Santi","year":"2020","journal-title":"Mol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00018-020-03526-7","article-title":"What microRNAs could tell us about the human X chromosome","volume":"77","author":"Di Palo","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","article-title":"Xist ribonucleoproteins promote female sex-biased autoimmunity","volume":"187","author":"Dou","year":"2024","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170696","article-title":"LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway","volume":"37","author":"Du","year":"2017","journal-title":"Biosci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/SCIENCE.1126316","article-title":"The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene","volume":"312","author":"Duret","year":"2006","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e2521","DOI":"10.1371\/journal.pone.0002521","article-title":"A dual origin of the Xist gene from a protein-coding gene and a set of transposable elements","volume":"3","author":"Elisaphenko","year":"2008","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1164\/rccm.201903-0508OC","article-title":"MicroRNA let-7 downregulates ligand-independent estrogen receptor\u2013mediated male-predominant pulmonary fibrosis","volume":"200","author":"Elliot","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13293-022-00420-8","article-title":"Considerations and challenges for sex-aware drug repurposing","volume":"13","author":"Fisher","year":"2022","journal-title":"Biol. Sex. Differ."},{"key":"B46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.omtn.2023.08.023","article-title":"Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers","volume":"33","author":"Fitzsimons","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/ph12020078","article-title":"Tegsedi (Inotersen): an antisense oligonucleotide approved for the treatment of adult patients with hereditary transthyretin amyloidosis","volume":"12","author":"Gales","year":"2019","journal-title":"Pharm. (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1406432","DOI":"10.1080\/23723556.2017.1406432","article-title":"miRNA displacement as a promising approach for cancer therapy","volume":"5","author":"Gilot","year":"2018","journal-title":"Mol. Cell. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11171","article-title":"Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivation","volume":"487","author":"Grant","year":"2012","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/jc.2012-2382","article-title":"Klinefelter syndrome - a clinical update","volume":"98","author":"Groth","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cell.2013.06.009","article-title":"Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins","volume":"154","author":"Guttman","year":"2013","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4110\/in.2011.11.3.135","article-title":"MicroRNAs in human diseases: from cancer to cardiovascular disease","volume":"11","author":"Ha","year":"2011","journal-title":"Immune Netw."},{"key":"B53","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.jacadv.2025.101900","article-title":"Impact of sex and age on trends of mortality from infective endocarditis in high-income countries","volume":"4","author":"Hibino","year":"2025","journal-title":"JACC. Adv."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1021\/acssynbio.3c00253","article-title":"Making the next generation of therapeutics: mRNA meets synthetic biology","volume":"12","author":"H\u0131n\u00e7er","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1027401","DOI":"10.3389\/FDDSV.2022.1027401","article-title":"The grand challenge of discovering new cardiovascular drugs","volume":"2","author":"Hong","year":"2022","journal-title":"Front. Drug Discov."},{"key":"B56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s003350010040","article-title":"A revision of the human XIST gene organization and structural comparison with mouse Xist","volume":"11","author":"Hong","year":"2000","journal-title":"Mamm. Genome"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s44161-024-00441-z","article-title":"Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure","volume":"3","author":"Horitani","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1126\/SCIENCE.AAY0262","article-title":"Pervasive functional translation of noncanonical human open reading frames","volume":"367","author":"Hou","year":"2020","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/S0387-7604(01)00344-8","article-title":"The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome","volume":"23","author":"Ishii","year":"2001","journal-title":"Brain Dev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","article-title":"Life of RISC: formation, action, and degradation of RNA-induced silencing complex","volume":"82","author":"Iwakawa","year":"2022","journal-title":"Mol. Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cell.2011.06.026","article-title":"YY1 Tethers Xist RNA to the inactive X nucleation center","volume":"146","author":"Jeon","year":"2011","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41525-023-00387-4","article-title":"Breaking the mold with RNA-a \u201cRNAissance\u201d of life science","volume":"9","author":"Jones","year":"2024","journal-title":"NPJ Genomic Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1128\/MCB.02269-07","article-title":"Xist RNA is confined to the nuclear territory of the silenced X chromosome throughout the cell cycle","volume":"28","author":"Jonkers","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.pneurobio.2019.101664","article-title":"microRNA dysregulation in neurodegenerative diseases: a systematic review","volume":"182","author":"Ju\u017awik","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"C742","DOI":"10.1152\/ajpcell.00358.2020","article-title":"Sex omission and male bias are still widespread in cell experiments","volume":"320","author":"Kim","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1161\/CIR.0000000000001310","article-title":"Sex differences in peripheral vascular disease: a scientific statement from the American heart association","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40348-020-0093-x","article-title":"Random X chromosome inactivation in patients with Klinefelter syndrome","volume":"7","author":"Kinjo","year":"2020","journal-title":"Mol. Cell. Pediatr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.106.622621","article-title":"Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy","volume":"115","author":"Kyndt","year":"2007","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1113673","article-title":"Molecular biology: regulation of X-chromosome counting by Tsix and Xite sequences","volume":"309","author":"Lee","year":"2005","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.omtn.2019.10.004","article-title":"Inhibition of lncRNA XIST improves myocardial I\/R injury by targeting miR-133a through inhibition of autophagy and regulation of SOCS2","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.gendis.2022.04.007","article-title":"Long noncoding RNA XIST: mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities","volume":"9","author":"Li","year":"2022","journal-title":"Genes Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.18632\/AGING.103072","article-title":"LncRNA XIST promotes myocardial infarction by regulating FOS through targeting miR-101a-3p","volume":"12","author":"Lin","year":"2020","journal-title":"Aging (Albany. NY)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"30939","DOI":"10.1038\/srep30939","article-title":"Efficient suppression of hepatitis C virus replication by combination treatment with MIR-122 antagonism and direct-acting antivirals in cell culture systems","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13046-018-0950-9","article-title":"LncRNA XIST\/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","article-title":"Structure and degradation of circular RNAs regulate PKR activation in innate immunity","volume":"177","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12017-014-8295-9","article-title":"Rett syndrome and MeCP2","volume":"16","author":"Liyanage","year":"2014","journal-title":"NeuroMolecular Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1038\/s41467-025-61092-7","article-title":"Targeting microRNA-dependent control of X chromosome inactivation improves the Rett syndrome phenotype","volume":"16","author":"Lou","year":"2025","journal-title":"Nat. Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.4049\/jimmunol.179.9.6352","article-title":"Demethylation of CD40LG on the inactive X in T cells from women with lupus","volume":"179","author":"Lu","year":"2007","journal-title":"J. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/VACCINES9101187","article-title":"Self-replicating RNA viruses for vaccine development against infectious diseases and cancer","volume":"9","author":"Lundstrom","year":"2021","journal-title":"Vaccines"},{"key":"B82","doi-asserted-by":"publisher","first-page":"113804","DOI":"10.1016\/j.addr.2021.05.014","article-title":"Let\u2019s talk about sex: differences in drug therapy in males and females","volume":"175","author":"Madla","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tibs.2015.12.003","article-title":"Fitting the puzzle pieces: the bigger picture of XCI","volume":"41","author":"Maduro","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ymthe.2018.11.018","article-title":"mRNA-Based protein replacement therapy for the heart","volume":"27","author":"Magadum","year":"2019","journal-title":"Mol. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0221371","DOI":"10.1371\/journal.pone.0221371","article-title":"Beyond sequence homology: cellular biology limits the potential of XIST to act as a miRNA sponge","volume":"14","author":"Marshall","year":"2019","journal-title":"PLoS One"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American heart association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.3390\/CIMB44100341","article-title":"Lipid nanoparticles: a novel gene delivery technique for clinical application","volume":"44","author":"Mashima","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","article-title":"Acute myocardial infarction in women: a scientific statement from the American heart association","volume":"133","author":"Mehta","year":"2016","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/J.JACC.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1096\/fj.201600781R","article-title":"Considering sex as a biological variable in preclinical research","volume":"31","author":"Miller","year":"2017","journal-title":"FASEB J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1172\/JCI34470","article-title":"A skewed view of X chromosome inactivation","volume":"118","author":"Minks","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.abe0348","article-title":"Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen","volume":"374","author":"Montasser","year":"2021","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/D41573-024-00070-Y","article-title":"RNA-editing drugs advance into clinical trials","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B95","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bcmd.2014.10.001","article-title":"Identification of novel informative loci for DNA-based X-inactivation analysis","volume":"54","author":"Musalkova","year":"2015","journal-title":"Blood Cells. Mol. Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/JA505986A","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1101\/GAD.271203","article-title":"Skewing X chromosome choice by modulating sense transcription across the Xist locus","volume":"17","author":"Nesterova","year":"2003","journal-title":"Genes Dev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/AJMG.C.31799","article-title":"Epigenetic and transcriptomic consequences of excess X-chromosome material in 47,XXX syndrome-A comparison with Turner syndrome and 46,XX females","volume":"184","author":"Nielsen","year":"2020","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1016\/S1473-3099(24)00615-7","article-title":"12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1086\/302095","article-title":"X chromosome inactivation in carriers of Barth syndrome","volume":"63","author":"\u00d8rstavik","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/ajmg.a.33334","article-title":"Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy","volume":"152","author":"Ottesen","year":"2010","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B102","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/HMG\/DDAF160","article-title":"Impact of somatic XIST deletions on ongoing XIST expression and inactive X silencing and heterochromatin","volume":"26","author":"Owens","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"B103","unstructured":"Small interfering RNA (siRNA) therapy\n          \n          \n            \n              Padda\n              I. S.\n            \n            \n              Mahtani\n              A. U.\n            \n            \n              Patel\n              P.\n            \n            \n              Parmar\n              M.\n            \n          \n          \n          2024"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/nejm199801293380504","article-title":"X-Linked Wiskott\u2013Aldrich syndrome in a girl","volume":"338","author":"Parolini","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng1197-353","article-title":"A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation","volume":"17","author":"Plenge","year":"1997","journal-title":"Nat. Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/HMG\/DDI089","article-title":"Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation","volume":"14","author":"Pugacheva","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ng0597-54","article-title":"Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome","volume":"16","author":"Rao","year":"1997","journal-title":"Nat. Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","article-title":"Sex differences in the cardiovascular consequences of diabetes mellitus a scientific statement from the American heart association","volume":"132","author":"Regensteiner","year":"2015","journal-title":"Circulation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-023-06457-y","article-title":"The complete sequence of a human Y chromosome","volume":"621","author":"Rhie","year":"2023","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e2529104","DOI":"10.1001\/jamanetworkopen.2025.29104","article-title":"Participation of Women in cardiovascular trials from 2017 to 2023: a systematic review","volume":"8","author":"Rivera","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"B114","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/S41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e78263","DOI":"10.7554\/eLife.78263","article-title":"Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans","volume":"11","author":"Roberts","year":"2022","journal-title":"Elife"},{"key":"B116","first-page":"14","article-title":"Fomivirsen approved for CMV retinitis","volume":"4","author":"Roehr","year":"1998","journal-title":"J. Int. Assoc. Physicians AIDS Care"},{"key":"B117","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/NATURE03440","article-title":"The DNA sequence of the human X chromosome","volume":"434","author":"Ross","year":"2005","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double\u2010blind, placebo\u2010controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e180078","DOI":"10.1172\/JCI180078","article-title":"Revisiting sex as a biological variable in hypertension research","volume":"134","author":"Ryan","year":"2024","journal-title":"J. Clin. Invest."},{"key":"B120","doi-asserted-by":"publisher","first-page":"20160365","DOI":"10.1098\/rstb.2016.0365","article-title":"What makes the maternal X chromosome resistant to undergoing imprinted X inactivation?","volume":"372","author":"Sado","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.tcb.2018.05.005","article-title":"The role of xist in X-Chromosome dosage compensation","volume":"28","author":"Sahakyan","year":"2018","journal-title":"Trends Cell Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the rosetta stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1128\/MCB.00810-06","article-title":"Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation","volume":"26","author":"Savarese","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40265-020-01269-0","article-title":"Givosiran: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1242\/DEV.056812","article-title":"Disruption of a conserved region of Xist exon 1 impairs Xist RNA localisation and X-linked gene silencing during random and imprinted X chromosome inactivation","volume":"138","author":"Senner","year":"2011","journal-title":"Development"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of MicroRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/S00109-022-02205-3","article-title":"X-linked genes exhibit miR6891-5p-regulated skewing in Sj\u00f6gren\u2019s syndrome","volume":"100","author":"Shaw","year":"2022","journal-title":"J. Mol. Med. (Berl)."},{"key":"B130","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/S41587-019-0106-2","article-title":"Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index","volume":"37","author":"Shen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/S00018-020-03500-3","article-title":"Xist attenuates acute inflammatory response by female cells","volume":"78","author":"Shenoda","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/vaccines12030318","article-title":"Self-amplifying RNA: a second revolution of mRNA vaccines against COVID-19. Vaccines 12","volume":"12","author":"Silva-Pilipich","year":"2024","journal-title":"Vaccines (Basel)."},{"key":"B133","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.TEM.2008.04.002","article-title":"Boys, girls and shuttling of SRY and SOX9","volume":"19","author":"Sim","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/d44151-025-00036-y","article-title":"Women are poorly represented in clinical trials. That\u2019s problematic","volume":"2025","author":"Singh","year":"2025","journal-title":"Nat. India"},{"key":"B135","doi-asserted-by":"publisher","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci. Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"114007","DOI":"10.1016\/j.addr.2021.114007","article-title":"Delivery of synthetic mRNAs for tissue regeneration","volume":"179","author":"Steinle","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/NAR\/GKY1198","article-title":"Developmental Xist induction is mediated by enhanced splicing","volume":"47","author":"Stork","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/(SICI)1096-8628(19981204)80:4<356::AID-AJMG10>3.0.CO;2-O","article-title":"Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne\/Becker female carriers","volume":"80","author":"Sumita","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"B139","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/pharmaceutics15020622","article-title":"mRNA-Based therapeutics in cancer treatment","volume":"15","author":"Sun","year":"2023","journal-title":"Pharmaceutics"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e32597","DOI":"10.1016\/j.heliyon.2024.e32597","article-title":"Sex as a biological variable in early-phase oncology clinical trials: enhancing the path to personalised medicine","volume":"10","author":"Sutherland","year":"2024","journal-title":"Heliyon"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1182\/blood-2011-11-390351","article-title":"Methylation of AR locus does not always reflect X chromosome inactivation state","volume":"119","author":"Swierczek","year":"2012","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e126751","DOI":"10.1172\/jci.insight.126751","article-title":"Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases","volume":"4","author":"Syrett","year":"2019","journal-title":"JCI Insight"},{"key":"B143","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B144","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-5-8","article-title":"A review of trisomy X (47,XXX)","volume":"5","author":"Tartaglia","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1242\/JCS.00111","article-title":"Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist","volume":"115","author":"Turner","year":"2002","journal-title":"J. Cell Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"H238","DOI":"10.1152\/ajpheart.00535.2023","article-title":"Guidelines on the use of sex and gender in cardiovascular research","volume":"326","author":"Usselman","year":"2024","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e2952","DOI":"10.1002\/JGM.2952","article-title":"Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy","volume":"19","author":"Viggiano","year":"2017","journal-title":"J. Gene Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1128067","DOI":"10.3389\/fmolb.2023.1128067","article-title":"Translation of in vitro-transcribed RNA therapeutics","volume":"10","author":"von der Haar","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.3390\/ijms25105351","article-title":"Human and murine toll-like receptor-driven disease in systemic lupus erythematosus","volume":"25","author":"von Hofsten","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"E2029","DOI":"10.1073\/pnas.1520113113","article-title":"Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B152","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"B153","doi-asserted-by":"publisher","first-page":"82","DOI":"10.46497\/ArchRheumatol.2022.9250","article-title":"LncRNA XIST promotes adjuvant-induced arthritis by increasing the expression of YY1 via miR-34a-5p","volume":"38","author":"Wei","year":"2023","journal-title":"Arch. Rheumatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"key":"B155","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/NI0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat. Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2016.01.006","article-title":"The X factor: x chromosome dosage compensation in the evolutionarily divergent monotremes and marsupials","volume":"56","author":"Whitworth","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/NG820","article-title":"Chromosomal silencing and localization are mediated by different domains of Xist RNA","volume":"30","author":"Wutz","year":"2002","journal-title":"Nat. Genet."},{"key":"B158","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1002\/jcp.28047","article-title":"The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101","volume":"234","author":"Xiao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e1005430","DOI":"10.1371\/JOURNAL.PGEN.1005430","article-title":"Xist exon 7 contributes to the stable localization of xist RNA on the inactive X-Chromosome","volume":"11","author":"Yamada","year":"2015","journal-title":"PLoS Genet."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41374-021-00635-0","article-title":"LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition","volume":"101","author":"Yan","year":"2021","journal-title":"Lab. Investig."},{"key":"B161","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/S41541-025-01260-4","article-title":"Immunization with virus-like vesicle-based COVID-19 vaccine induces robust systemic and mucosal immunity","volume":"10","author":"Yang","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.101197","article-title":"Xist RNA binds select autosomal genes and depends on repeat B to regulate their expression","volume":"13","author":"Yao","year":"2025","journal-title":"Elife"},{"key":"B163","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.isci.2019.10.040","article-title":"Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B","volume":"21","author":"Yarovinsky","year":"2019","journal-title":"iScience"},{"key":"B164","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ANA.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"vdac119","DOI":"10.1093\/NOAJNL\/VDAC119","article-title":"Modulating glioblastoma chemotherapy response: evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function","volume":"4","author":"Yuan","year":"2022","journal-title":"Hypoxic Processes"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol. Ther."},{"key":"B167","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/NBT.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12935-019-0909-8","article-title":"lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"B169","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1038\/s41467-024-49764-2","article-title":"X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"B170","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.18632\/AGING.204075","article-title":"A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction","volume":"14","author":"Zheng","year":"2022","journal-title":"Aging (Albany. NY)."},{"key":"B171","doi-asserted-by":"publisher","first-page":"8659","DOI":"10.1002\/jcp.26327","article-title":"LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p","volume":"234","author":"Zhou","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.26355\/eurrev_202002_20193","article-title":"LncRNA XIST inhibits hypoxia-induced cardiomyocyte apoptosis via mediating miR-150-5p\/Bax in acute myocardial infarction","volume":"24","author":"Zhou","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B173","first-page":"3501","article-title":"The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5","volume":"12","author":"Zong","year":"2020","journal-title":"Am. J. Transl. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1716863\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:38:51Z","timestamp":1768196331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1716863\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":173,"alternative-id":["10.3389\/fphar.2025.1716863"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1716863","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1716863"}}